Science 37 Holdings, Inc., formerly associated with blank-check company LifeSci Acquisition Corp. (Nasdaq: LSAQ), filed an amended annual report on Form 10-K/A with the SEC on December 20, 2021. The SPAC was sponsored by LifeSci Capital LLC, a life sciences-focused investment firm, and completed its initial public offering in 2020. The vehicle targeted the healthcare and life sciences sector, ultimately combining with Science 37, a technology-enabled decentralized clinical trial company. The 10-K/A reflects the post-merger combined entity operating under the Science 37 Holdings name following completion of the de-SPAC transaction. Sign up for a SpacDesk account to access the full filing history, sponsor profiles, and deal analytics for LSAQ and hundreds of other SPACs.